文献速递环境卫生慢病防控与筛查

空气污染物与乳腺癌风险:五项美国大型前瞻性队列的平行分析

Air Pollutants and Breast Cancer Risk: A Parallel Analysis of Five Large US Prospective Cohorts.
PubMed 文献 · Am J Public Health · 2025-09-25

该研究基于美国五项大型前瞻性队列,采用高分辨率时空模型估算居住地二氧化氮(NO₂)、细颗粒物(PM2.5)和臭氧浓度,用Cox比例风险回归和随机效应模型分析其与乳腺癌发病的关联。结果显示NO₂与总体乳腺癌发病呈正相关(HR=1.03;95%CI=1.00,1.05),PM2.5和臭氧与雌激素受体阴性/孕激素受体阴性(ER-/PR-)肿瘤发病升高相关。

要点

  • NO₂与总体乳腺癌发病呈正相关(HR=1.03;95%CI=1.00,1.05)。
  • PM2.5与ER-/PR-肿瘤发病升高相关(HR=1.14;95%CI=1.04,1.24)。
  • 臭氧与ER-/PR-肿瘤发病升高相关(HR=1.10;95%CI=1.00,1.21)。

核心结论

  • 在这项迄今美国最大的研究中,确认了NO₂与乳腺癌的关联,并首次呈现PM2.5和臭氧与ER-/PR-肿瘤的新关联。

研究设计与样本

  • 平行分析美国五项大型前瞻性队列:护士健康研究、妇女健康倡议临床试验和观察性研究队列、姐妹研究。
  • 采用高分辨率时空模型估算居住地NO₂(ppb)、PM2.5(≤2.5 μ/m³)和臭氧(ppb)浓度。
  • 采用Cox比例风险回归估计各队列风险比(HR)和95%置信区间(CI),随机效应模型确定汇总HR,并按ER/PR亚型和普查区域分析。

主要发现

  • NO₂与总体乳腺癌发病呈正相关(n=28 811例;HR=1.03;95%CI=1.00,1.05),各亚组间变异较小。
  • PM2.5与ER-/PR-肿瘤发病升高相关(n=2 367例;HR=1.14;95%CI=1.04,1.24;异质性P<.001)。
  • PM2.5与中西部总体乳腺癌发病升高相关(HR=1.15;95%CI=1.01,1.32;异质性P=.01)。
  • 臭氧与总体乳腺癌发病无关联,但与ER-/PR-肿瘤发病升高相关(n=3 406例;HR=1.10;95%CI=1.00,1.21;异质性P=.03)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives. To determine whether outdoor air pollution exposure is associated with breast cancer incidence. Methods. Residential-level concentrations of nitrogen dioxide (NO2, parts per billion [ppb]), fine particulate matter (PM2.5; ≤ 2.5 μ/m3) and ozone (ppb) in the United States were estimated for participants of the Nurses' Health Studies, Women's Health Initiative Clinical Trials and Observational Study Cohort, and Sister Study using high-resolution spatiotemporal models. Cox proportional hazards regression estimated cohort-specific hazard ratios (HRs) and 95% confidence intervals (CIs), and a random effects model determined summary HRs, overall and by estrogen receptor (ER)/progesterone receptor (PR) subtype and census region. Results. NO2 was positively associated with overall breast cancer incidence (n = 28 811 cases; HR = 1.03; 95% CI = 1.00, 1.05), with little variation by subgroups. PM2.5 was associated with higher incidence of ER-/PR- tumors (n = 2367 cases; HR = 1.14; 95% CI = 1.04, 1.24; P-heterogeneity < .001) and with higher overall incidence in the Midwest (HR = 1.15; 95% CI = 1.01, 1.32; P-heterogeneity = .01). Ozone was not associated with overall incidence, but was associated with ER-/PR- tumors (n = 3406 cases; HR = 1.10; 95% CI = 1.00, 1.21; P-heterogeneity = .03). Conclusions. In this largest US study to date, we confirmed an association between NO2 and breast cancer, and we present novel associations of PM2.5 and ozone with ER-/PR- tumors. (Am J Public Health. 2025;115(12): 2030-2043. https://doi.org/10.2105/AJPH.2025.308247).

来源:Am J Public Health,查看原文。版权归原作者所有。

引用

  1. White AJ, Hart JE, Quraishi SM, et al. Air Pollutants and Breast Cancer Risk: A Parallel Analysis of Five Large US Prospective Cohorts. Am J Public Health. 2025. PMID: 40998424. doi:10.2105/AJPH.2025.308247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。